Beijing Beilu Pharmaceutical Co.,Ltd.’s Net Profit Dropped 85.6% in First Half of 2023

Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陆药业股份有限公司) (300016.SZ) reported a net profit of 5 million yuan in the first half of 2023, down 85.6% year-on-year.

Meanwhile, the company posted 438 million yuan in revenue, up 24.7% year-on-year.

At the end of the reporting period, it had 2.8 billion yuan in total assets and 939.4 million yuan in total liabilities, with a liability-to-asset ratio of 33.2%.